A RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, PHASE . STUDY EVALUATING THE EFFICACY AND SAFETY OF HETROMBOPAG OLAMINE TABLETS VS PLACEBO IN PATIENTS WITH CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA

Registry ID

SHR8735-303

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.

Last update

2026-04-21

Conditions

• THROMBOCYTOPENIA

Related clinical trials

• AN INTERVENTIONAL PHASE 2, OPEN-LABEL, ONE-ARM, MULTICENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMOBOCYTOPENIA
• A RANDOMIZED CONTROLLED PHASE 3 STUDY OF ORAL PACRITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH THROMBOCYTOPENIA AND PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS, OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS.

View on source registry